Laboratory J. Andrew Pospisilik

Zoom

Epigenetic control of complex disease


Current estimates place the prevalence of diabetes and obesity in the range of 300 million to beyond 1 billion by the year 2030. As critical risk factors for heart disease, cancer and stroke, obesity and diabetes currently represent one of the world's chief economic and health care challenges. While studies have established elegant genetic frameworks for our current understanding of these complex disorders, the contribution of a number of critical regulatory layers, in particular epigenetic regulation, remain poorly understood.
Our lab is interested in defining epigenetic regulatory systems that contribute to the susceptibility and development of complex disease. These paradigms are broad and include, among others, post-translational modifications of histones, non-coding RNAs, and modifiers of chromatin stability such as the Polycomb-Trithorax Groups. What is clear at present is that these epigenetic effectors play a critical role in defining set-points for entire functional gene sets; the fundamental outstanding question we are interested in is how these epigenetic cues influence the susceptibility and development of human disease.


Group Leader

J. Andrew Pospisilik
phone: -757

pospisilik@ie-freiburg.mpg.de

1976
Born in Vancouver, Canada
Undergraduate studies in Physiology at the University of British Columbia, Vancouver, Canada

2003
PhD studies at the University of British Columbia, Vanvouver, Canada

2004-2009
Postdoctoral fellow at the Institute of Molecular Biotechnology, Vienna, Austria

Since March 2010
Group Leader at the Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany

Project Areas

  • Epigenetic Control of Complex Disease

    Epigenetic Control of Complex Disease

    Chromatin plasticity in metabolism and cancer. Introduction. Current estimates place the prevalence of diabetes and obesity in the range of 300 million to...

    more details >

  • Functional translation of epigenetic cues

    Functional translation of epigenetic cues

    A compliment to the first strategy, our second long-term goal is to functionally characterize disease-specific epigenetic modifications in vivo. These studies,...

    more details >

Recent Publications

Group Members